Ocaliva 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FDQYL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,640
Award facts
- Contract value 100% obligated
- $20,640.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,640.20 to DMS Pharmaceutical Group Inc. for the supply of Ocaliva 10 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a component of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026. The awardee, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, specializes in providing comprehensive pharmaceutical product distribution to federal healthcare systems, particularly military medical facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its SPE2DB program contract with the DLA, which enables the issuance of firm fixed-price delivery orders for prescription medications, biologics, and medical consumables. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products ranging from specialty medications to over-the-counter items across military health facilities nationwide. This delivery order for Ocaliva 10 mg tablets aligns with the company's core business of supporting Department of Defense healthcare sites with essential pharmaceutical supplies.
Quick answers
Who was awarded contract SPE2DB25FDQYL?
SPE2DB25FDQYL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FDQYL worth?
The government has obligated $20,640 on SPE2DB25FDQYL.
Is contract SPE2DB25FDQYL an order under another contract?
Yes. SPE2DB25FDQYL is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQYL competed?
The extent of competition for SPE2DB25FDQYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award